Dr McQuinlan recently joined Corin Dann on Radio New Zealand’s Morning Report to discuss the current status of Pharmac funding for Wegovy® in New Zealand. In the conversation, they explore what Pharmac funding could mean for patients, including improved access to evidence-based treatment and greater recognition of obesity as a chronic medical condition. Dr McQuinlan also speaks to the challenges many patients face when effective medications aren’t publicly funded, and why treatments like Wegovy® can play an important role alongside lifestyle and nutritional support. It’s a helpful listen for anyone wanting to better understand the current landscape, what this means for you, and what may change in the future. Listen to the podcast below to hear what he had to say.
Comments